Clin Otolaryngol:使用助听器前庭神经鞘瘤患者中,听力脑干响应研究

2018-04-10 AlexYang MedSci原创

单边前庭神经鞘瘤(VS)之后的听力损失对非手术患者的社会生活能够产生影响。最近,有研究人员调查了听力脑干响应(ABRs)在预测这些患者听觉重建结果中的使用表现情况。研究是一个前瞻性的研究,在一个大学高等医学中心进行。研究总共包括了25名患者,15名在"不同的ABR"组(即具有不同的响应波),10名在"去同步ABR"组中(即没有听力脑干响应)。研究发现,在助听器使用条件下,语言认知阈值(p<0

单边前庭神经鞘瘤(VS)之后的听力损失对非手术患者的社会生活能够产生影响。最近,有研究人员调查了听力脑干响应(ABRs)在预测这些患者听觉重建结果中的使用表现情况。研究是一个前瞻性的研究,在一个大学高等医学中心进行。

研究总共包括了25名患者,15名在"不同的ABR"组(即具有不同的响应波),10名在"去同步ABR"组中(即没有听力脑干响应)。研究发现,在助听器使用条件下,语言认知阈值(p<0.0001; W=-120)和语言区分得分(p=0.0005; W=78)与不使用助听器相比,具有显著的改善。这些改善在去同步组中不存在,语言认知阈值(p=0.48;W=-10)和语言区分得分(p=0.06; W=15)。另外,在不同的ABR组中,93%患者在试验之后仍旧保持听力助听器的使用,而去同步组中只有20%。

最后,研究人员指出,在单边非手术VS患者中,ABR能够帮助人们预测听力重建后的听觉表现。

原始出处:

Reffet K, Lescanne E, Bobillier C et al. Hearing aids in patients with vestibular schwannoma: interest of the auditory brainstem responses. Clin Otolaryngol. 25 Mar 2018.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2078114, encodeId=9bb020e8114f0, content=<a href='/topic/show?id=5f8284836ab' target=_blank style='color:#2F92EE;'>#脑干响应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84836, encryptionId=5f8284836ab, topicName=脑干响应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Apr 15 03:46:00 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076446, encodeId=1dea20e644698, content=<a href='/topic/show?id=d7453259e86' target=_blank style='color:#2F92EE;'>#前庭神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32597, encryptionId=d7453259e86, topicName=前庭神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Wed Jan 02 01:46:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306187, encodeId=bb23130618e6a, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Thu Apr 12 10:46:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307933, encodeId=2fd0130e933a2, content=<a href='/topic/show?id=c2e8333e6d8' target=_blank style='color:#2F92EE;'>#助听器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33376, encryptionId=c2e8333e6d8, topicName=助听器)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Thu Apr 12 10:46:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340168, encodeId=b20a13401684e, content=<a href='/topic/show?id=d0c3e4615f2' target=_blank style='color:#2F92EE;'>#神经鞘瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74615, encryptionId=d0c3e4615f2, topicName=神经鞘瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Thu Apr 12 10:46:00 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2078114, encodeId=9bb020e8114f0, content=<a href='/topic/show?id=5f8284836ab' target=_blank style='color:#2F92EE;'>#脑干响应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84836, encryptionId=5f8284836ab, topicName=脑干响应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Apr 15 03:46:00 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076446, encodeId=1dea20e644698, content=<a href='/topic/show?id=d7453259e86' target=_blank style='color:#2F92EE;'>#前庭神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32597, encryptionId=d7453259e86, topicName=前庭神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Wed Jan 02 01:46:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306187, encodeId=bb23130618e6a, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Thu Apr 12 10:46:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307933, encodeId=2fd0130e933a2, content=<a href='/topic/show?id=c2e8333e6d8' target=_blank style='color:#2F92EE;'>#助听器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33376, encryptionId=c2e8333e6d8, topicName=助听器)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Thu Apr 12 10:46:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340168, encodeId=b20a13401684e, content=<a href='/topic/show?id=d0c3e4615f2' target=_blank style='color:#2F92EE;'>#神经鞘瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74615, encryptionId=d0c3e4615f2, topicName=神经鞘瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Thu Apr 12 10:46:00 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2078114, encodeId=9bb020e8114f0, content=<a href='/topic/show?id=5f8284836ab' target=_blank style='color:#2F92EE;'>#脑干响应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84836, encryptionId=5f8284836ab, topicName=脑干响应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Apr 15 03:46:00 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076446, encodeId=1dea20e644698, content=<a href='/topic/show?id=d7453259e86' target=_blank style='color:#2F92EE;'>#前庭神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32597, encryptionId=d7453259e86, topicName=前庭神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Wed Jan 02 01:46:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306187, encodeId=bb23130618e6a, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Thu Apr 12 10:46:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307933, encodeId=2fd0130e933a2, content=<a href='/topic/show?id=c2e8333e6d8' target=_blank style='color:#2F92EE;'>#助听器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33376, encryptionId=c2e8333e6d8, topicName=助听器)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Thu Apr 12 10:46:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340168, encodeId=b20a13401684e, content=<a href='/topic/show?id=d0c3e4615f2' target=_blank style='color:#2F92EE;'>#神经鞘瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74615, encryptionId=d0c3e4615f2, topicName=神经鞘瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Thu Apr 12 10:46:00 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
    2018-04-12 ysjykql
  4. [GetPortalCommentsPageByObjectIdResponse(id=2078114, encodeId=9bb020e8114f0, content=<a href='/topic/show?id=5f8284836ab' target=_blank style='color:#2F92EE;'>#脑干响应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84836, encryptionId=5f8284836ab, topicName=脑干响应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Apr 15 03:46:00 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076446, encodeId=1dea20e644698, content=<a href='/topic/show?id=d7453259e86' target=_blank style='color:#2F92EE;'>#前庭神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32597, encryptionId=d7453259e86, topicName=前庭神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Wed Jan 02 01:46:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306187, encodeId=bb23130618e6a, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Thu Apr 12 10:46:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307933, encodeId=2fd0130e933a2, content=<a href='/topic/show?id=c2e8333e6d8' target=_blank style='color:#2F92EE;'>#助听器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33376, encryptionId=c2e8333e6d8, topicName=助听器)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Thu Apr 12 10:46:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340168, encodeId=b20a13401684e, content=<a href='/topic/show?id=d0c3e4615f2' target=_blank style='color:#2F92EE;'>#神经鞘瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74615, encryptionId=d0c3e4615f2, topicName=神经鞘瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Thu Apr 12 10:46:00 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2078114, encodeId=9bb020e8114f0, content=<a href='/topic/show?id=5f8284836ab' target=_blank style='color:#2F92EE;'>#脑干响应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84836, encryptionId=5f8284836ab, topicName=脑干响应)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Apr 15 03:46:00 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076446, encodeId=1dea20e644698, content=<a href='/topic/show?id=d7453259e86' target=_blank style='color:#2F92EE;'>#前庭神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32597, encryptionId=d7453259e86, topicName=前庭神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Wed Jan 02 01:46:00 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306187, encodeId=bb23130618e6a, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Thu Apr 12 10:46:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307933, encodeId=2fd0130e933a2, content=<a href='/topic/show?id=c2e8333e6d8' target=_blank style='color:#2F92EE;'>#助听器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33376, encryptionId=c2e8333e6d8, topicName=助听器)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Thu Apr 12 10:46:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340168, encodeId=b20a13401684e, content=<a href='/topic/show?id=d0c3e4615f2' target=_blank style='color:#2F92EE;'>#神经鞘瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74615, encryptionId=d0c3e4615f2, topicName=神经鞘瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Thu Apr 12 10:46:00 CST 2018, time=2018-04-12, status=1, ipAttribution=)]

相关资讯

J Clin Virol:通用新生儿听力筛选方法对新生儿巨细胞病毒感染和听力损失的鉴定

新生儿巨细胞病毒感染(CMV)是一种最为常见的非遗传性感官听力损失诱因。目前,在澳大利亚或者其他国家,对新生儿还没有通用的CMV筛选方法或者常规的听力损失新生儿CMV测试。最近,有研究人员利用常规的资源通过澳大利亚通用新生儿听力筛选(UNHS)计划对先天性CMV感染的听力损失新生儿的流行度进行了评估。研究发现,总共有1669名新生儿在2009年和2016年之间的UNHS中筛选失败。其中,30%(5

J Hum Genet:一个新的SMPX基因变异与X染色体连锁的非综合症感官听力损失相关

X染色体连锁的遗传是非常稀少的,并且据估计在所有的非综合征听力损失案例中只占据1%-5%的比例。最近,有研究人员发现了一个来源于中国的一个多元的家庭,表现出X染色体非综合征听力损失的分离。研究人员在通过全外显子组测序后,排除了3个听力损失相关基因(GJB2、mtDNA12srRNA和SLC26A4)的10个常见的变异后,发现了SMPX的一个新的变异位点c.87dupA (p.Gly30Argfs*

J EXP MED:研究人员找到针对听力损失的药物分子

老龄化,噪音,顺铂毒性或其他刺激引起的听力损失影响着全球范围内的3.6亿人,但至今为止,还没有预防或治疗听力损失的药物得到食品和药物管理局的批准。

Hear Res:单边听力损失儿童听力和语言结果研究

因为新生儿听力筛选过程,单边听力损失(UHL)儿童在很小的年龄时就能够被诊断。从传统的观点看,这些儿童在听力和语言发展过程中会存在障碍风险。儿童早期-出生前几个月的临时群体可利用信息很少。最近,有研究人员在一个早期鉴定的患有UHL的儿童临时性群体中调查了听力和语言学习结果,并且与他们的同龄的学前年龄的轻度双边听力损失和正常听力损失儿童进行了比较。研究人员在4年时间内搜集了患有单边、双边听力损失和具

Maturitas:在老年人中,言语和高频率听力损失以及抑郁、焦虑和压力之间的相关性研究

年龄相关的听力损失(ARHL)和抑郁被认为是导致老年人残疾的主导原因。最近,有研究人员进行了一个代表性的研究,调查了老年人中言语严重度和高频听力损失与抑郁、焦虑和压力之间的关系。研究包括了151名参与者(73名男性和78名女性,平均年龄为64.44±10.77岁)。研究人员根据他们的更好的耳朵听力(0.5, 1, 2和4kHz)和高频率(6和8kHz)听力阈值,将他们分成了3个小组:正常听力组、轻

Sci Rep:IDH2功能丧失能够加速年龄相关的听力损失

异柠檬酸脱氢酶(IDH)2参与了TCA循环并且能够催化异柠檬酸到α-酮戊二酸以及NADP+到NADPH的转化。在线粒体中,IDH2通过提供NADPH到谷胱甘肽还原酶(GSR)和硫氧还蛋白还原酶(TXNRD2),同样在保护线粒体组分免受氧化胁迫上具有重要的作用。最近,有研究人员报道了Idh2功能的丧失能够加速年龄相关的听力损失,这也是雄性小鼠最为常见的听力损伤形式。并且在24个月大的Idh2-/-小